T-Cell-Derived Nanovesicles for Cancer Immunotherapy

0
155
T-cell-derived nanovesicles produced by the serial extrusion of cytotoxic T cells through membranes with micro-/nanosized pores that inhibit T-cell exhaustion and exhibit antitumoral activity maintained in the immunosuppressive tumor microenvironment were presented.
[Advanced Materials]
Hong, J., Kang, M., Jung, M., Lee, Y. Y., Cho, Y., Kim, C., Song, S. Y., Park, C. G., Doh, J., & Kim, B.-S. (n.d.). T-Cell-Derived Nanovesicles for Cancer Immunotherapy. Advanced Materials, n/a(n/a), 2101110. https://doi.org/10.1002/adma.202101110 Cite
Abstract